The following Products are protected by U.S. patents as indicated below. This website is provided to satisfy the virtual patent marking provisions of 35 U.S.C. § 287(a). The patent information displayed on this page is believed to be accurate as of the most recent update of the page, but should not be considered exhaustive. In particular, omission of a particular patent from this page is not a representation or admission by Rigel Pharmaceuticals, Inc. that the patent does not cover the Product.

TAVALISSE® (fostamatinib disodium hexahydrate) tablets

7449458, 7538108, 7989448, 8163902, 8211889, 8263122, 8445485, 8652492, 8771648, 8912170, 8951504, 9266912, 9283238, RE48898

GAVRETO® (pralsetinib) capsules

10030005, 11273160, 11872192, 11963958, 12448366, 12539303

REZLIDHIA® (olutasidenib) capsules

9834539, 10414752, 10532047, 10550098, 10959994, 11013733, 11013734, 11376246, 11497743, 11498913, 11723905, 11738018, 12053463, 12275715